Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

40.47%

Threshold

Crossed downwards

Timeline

Published

08.06.2018

Transaction

01.06.2018

Transfer date

01.06.2018

Voting rights breakdown

Voting rights acquired7.98%

Voting rights sold40.47%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAI6600068

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX THERAPEUTICS LTD

Addex Therapeutics Ltd08.06.2018TAI6600068

Disclosure summary

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd on the disposal side, published by SIX Exchange Regulation on 08.06.2018, at 40.47% of voting rights. Notice category: Single shareholder.

Disclosed position

40.47%

Voting rights sold

Voting rights acquired7.98%

Voting rights sold40.47%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd, published on 08.06.2018.

Publication date08.06.2018

Transaction date01.06.2018

Transfer date01.06.2018

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX THERAPEUTICS LTD

Declared addressADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

CategorySingle shareholder

Voting rights acquired7.98%

Voting rights sold40.47%

Below threshold0%

ExchangeXSWX

Notification IDTAI6600068

Commercial register

CHE-113.514.094

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 08.06.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open